889 related articles for article (PubMed ID: 25738576)
1. Astragaloside IV protects against isoproterenol-induced cardiac hypertrophy by regulating NF-κB/PGC-1α signaling mediated energy biosynthesis.
Zhang S; Tang F; Yang Y; Lu M; Luan A; Zhang J; Yang J; Wang H
PLoS One; 2015; 10(3):e0118759. PubMed ID: 25738576
[TBL] [Abstract][Full Text] [Related]
2. Astragalus polysaccharide attenuates isoproterenol-induced cardiac hypertrophy by regulating TNF-α/PGC-1α signaling mediated energy biosynthesis.
Luan A; Tang F; Yang Y; Lu M; Wang H; Zhang Y
Environ Toxicol Pharmacol; 2015 May; 39(3):1081-90. PubMed ID: 25880160
[TBL] [Abstract][Full Text] [Related]
3. Astragaloside IV improves the isoproterenol-induced vascular dysfunction via attenuating eNOS uncoupling-mediated oxidative stress and inhibiting ROS-NF-κB pathways.
Xu C; Tang F; Lu M; Yang J; Han R; Mei M; Hu J; Zhou M; Wang H
Int Immunopharmacol; 2016 Apr; 33():119-27. PubMed ID: 26903414
[TBL] [Abstract][Full Text] [Related]
4. AdipoRon prevents l-thyroxine or isoproterenol-induced cardiac hypertrophy through regulating the AMPK-related pathway.
Hu X; Ou-Yang Q; Wang L; Li T; Xie X; Liu J
Acta Biochim Biophys Sin (Shanghai); 2019 Jan; 51(1):20-30. PubMed ID: 30566571
[TBL] [Abstract][Full Text] [Related]
5. Astragaloside IV attenuates inflammatory cytokines by inhibiting TLR4/NF-кB signaling pathway in isoproterenol-induced myocardial hypertrophy.
Yang J; Wang HX; Zhang YJ; Yang YH; Lu ML; Zhang J; Li ST; Zhang SP; Li G
J Ethnopharmacol; 2013 Dec; 150(3):1062-70. PubMed ID: 24432369
[TBL] [Abstract][Full Text] [Related]
6. Astragaloside IV attenuates apoptosis of hypertrophic cardiomyocyte through inhibiting oxidative stress and calpain-1 activation.
Mei M; Tang F; Lu M; He X; Wang H; Hou X; Hu J; Xu C; Han R
Environ Toxicol Pharmacol; 2015 Nov; 40(3):764-73. PubMed ID: 26433482
[TBL] [Abstract][Full Text] [Related]
7. G3BP2 is involved in isoproterenol-induced cardiac hypertrophy through activating the NF-κB signaling pathway.
Hong HQ; Lu J; Fang XL; Zhang YH; Cai Y; Yuan J; Liu PQ; Ye JT
Acta Pharmacol Sin; 2018 Feb; 39(2):184-194. PubMed ID: 28816235
[TBL] [Abstract][Full Text] [Related]
8. Astragaloside IV protects against cardiac hypertrophy via inhibiting the Ca2+/CaN signaling pathway.
Lu M; Wang H; Wang J; Zhang J; Yang J; Liang L; Maslov LN
Planta Med; 2014 Jan; 80(1):63-9. PubMed ID: 24338553
[TBL] [Abstract][Full Text] [Related]
9. Astragaloside IV attenuates injury caused by myocardial ischemia/reperfusion in rats via regulation of toll-like receptor 4/nuclear factor-κB signaling pathway.
Lu M; Tang F; Zhang J; Luan A; Mei M; Xu C; Zhang S; Wang H; Maslov LN
Phytother Res; 2015 Apr; 29(4):599-606. PubMed ID: 25604645
[TBL] [Abstract][Full Text] [Related]
10. The p65 subunit of NF-kappaB binds to PGC-1alpha, linking inflammation and metabolic disturbances in cardiac cells.
Alvarez-Guardia D; Palomer X; Coll T; Davidson MM; Chan TO; Feldman AM; Laguna JC; Vázquez-Carrera M
Cardiovasc Res; 2010 Aug; 87(3):449-58. PubMed ID: 20211864
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor gamma coactivator 1 alpha protects cardiomyocytes from hypertrophy by suppressing calcineurin-nuclear factor of activated T cells c4 signaling pathway.
Liu XP; Gao H; Huang XY; Chen YF; Feng XJ; He YH; Li ZM; Liu PQ
Transl Res; 2015 Nov; 166(5):459-473.e3. PubMed ID: 26118953
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of TNF-α-mediated NF-κB Activation by Ginsenoside Rg1 Contributes the Attenuation of Cardiac Hypertrophy Induced by Abdominal Aorta Coarctation.
Tang F; Lu M; Yu L; Wang Q; Mei M; Xu C; Han R; Hu J; Wang H; Zhang Y
J Cardiovasc Pharmacol; 2016 Oct; 68(4):257-264. PubMed ID: 27195652
[TBL] [Abstract][Full Text] [Related]
13. Arbutin Attenuates Isoproterenol-Induced Cardiac Hypertrophy by Inhibiting TLR-4/NF-κB Pathway in Mice.
Nalban N; Sangaraju R; Alavala S; Mir SM; Jerald MK; Sistla R
Cardiovasc Toxicol; 2020 Jun; 20(3):235-248. PubMed ID: 31485892
[TBL] [Abstract][Full Text] [Related]
14. Globular adiponectin inhibits angiotensin II-induced nuclear factor kappaB activation through AMP-activated protein kinase in cardiac hypertrophy.
Wang C; Li L; Zhang ZG; Fan D; Zhu Y; Wu LL
J Cell Physiol; 2010 Jan; 222(1):149-55. PubMed ID: 19780028
[TBL] [Abstract][Full Text] [Related]
15. Astragaloside IV Alleviates the Myocardial Damage Induced by Lipopolysaccharide via the Toll-Like Receptor 4 (TLR4)/Nuclear Factor kappa B (NF-κB)/Proliferator-Activated Receptor α (PPARα) Signaling Pathway.
Zhang X; Li M; Wang H
Med Sci Monit; 2019 Sep; 25():7158-7168. PubMed ID: 31545785
[TBL] [Abstract][Full Text] [Related]
16. Beneficial effects of astragaloside IV against angiotensin II-induced mitochondrial dysfunction in rat vascular smooth muscle cells.
Lu Y; Li S; Wu H; Bian Z; Xu J; Gu C; Chen X; Yang D
Int J Mol Med; 2015 Nov; 36(5):1223-32. PubMed ID: 26398547
[TBL] [Abstract][Full Text] [Related]
17. Cyclin-Dependent Kinase Inhibitor p21WAF1/CIP1 Facilitates the Development of Cardiac Hypertrophy.
Tong YF; Wang Y; Ding YY; Li JM; Pan XC; Lu XL; Chen XH; Liu Y; Zhang HG
Cell Physiol Biochem; 2017; 42(4):1645-1656. PubMed ID: 28746924
[TBL] [Abstract][Full Text] [Related]
18. The protective role of peroxisome proliferator-activated receptor γ coactivator-1α in hyperthyroid cardiac hypertrophy.
Xu W; Hou D; Jiang X; Lu Z; Guo T; Liu Y; Wang D; Zen K; Yu B; Zhang CY
J Cell Physiol; 2012 Sep; 227(9):3243-53. PubMed ID: 22105890
[TBL] [Abstract][Full Text] [Related]
19. Oleanonic acid ameliorates pressure overload-induced cardiac hypertrophy in rats: The role of PKCζ-NF-κB pathway.
Gao H; Liu H; Tang T; Huang X; Wang D; Li Y; Huang P; Peng Y
Mol Cell Endocrinol; 2018 Jul; 470():259-268. PubMed ID: 29138023
[TBL] [Abstract][Full Text] [Related]
20. COX-2 is involved in ET-1-induced hypertrophy of neonatal rat cardiomyocytes: role of NFATc3.
Li H; Gao S; Ye J; Feng X; Cai Y; Liu Z; Lu J; Li Q; Huang X; Chen S; Liu P
Mol Cell Endocrinol; 2014 Feb; 382(2):998-1006. PubMed ID: 24291639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
